• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

iScience . A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples

tetano

Editor, Senior Moderator
iScience


. 2021 Jul 21;102892.
doi: 10.1016/j.isci.2021.102892. Online ahead of print.
A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples


Tiantian Liu[SUP] 1 [/SUP], Zhong Chen[SUP] 1 [/SUP], Wanqiu Chen[SUP] 1 [/SUP], Xin Chen[SUP] 1 2 [/SUP], Maryam Hosseini[SUP] 1 [/SUP], Zhaowei Yang[SUP] 3 1 [/SUP], Jing Li[SUP] 3 2 [/SUP], Diana Ho[SUP] 1 [/SUP], David Turay[SUP] 4 [/SUP], Ciprian P Gheorghe[SUP] 5 [/SUP], Wendell Jones[SUP] 6 [/SUP], Charles Wang[SUP] 1 2 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging new type of coronavirus that is responsible for the COVID-19 pandemic and the unprecedented global health emergency. Whole-genome sequencing (WGS) of SARS-CoV-2 plays a critical role in understanding the disease. Performance variation exists across SARS-CoV-2 viral WGS technologies, but there is currently no benchmarking study comparing different WGS sequencing protocols. We compared seven different SARS-CoV-2 WGS library protocols using RNA from patient nasopharyngeal swab samples under two storage conditions with low and high viral inputs. We found large differences in mappability and genome coverage, and variations in sensitivity, reproducibility and precision of single-nucleotide variant calling across different protocols. For certain amplicon-based protocol, appropriate primer trimming step is critical for accurate single-nucleotide variant calling. We ranked the performance of protocols based on six different metrics. Our findings offer guidance in choosing appropriate WGS protocols to characterize SARS-CoV-2 and its evolution.
 
Back
Top Bottom